CSTONE ANNOUNCES MAJOR CLINICAL VALIDATION MILESTONE FOR CS2009 AT ESMO 2026: DATA FROM MORE THAN 300 PATIENTS SUPPORT MECHANISM, SAFETY AND BROAD ANTITUMOR ACTIVITY

Reuters · 1d ago

Please log in to view news